APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Papillomavirus Protein E7

Compare research editions
View pricing & licenses

Selected research

Industry Research

Human Papillomavirus Protein E7 Industry Research Report 2026

19 December 2025133 pages

Choose your research edition.

Industry ResearchHuman Papillomavirus Protein E7 Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Papillomavirus Protein E7 Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Human Papillomavirus Protein E7 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Papillomavirus Protein E7 Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Papillomavirus Protein E7 Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Human Papillomavirus Protein E7 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Human Papillomavirus Protein E7 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Human Papillomavirus Protein E7 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Human Papillomavirus Protein E7 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Human Papillomavirus Protein E7 include VLPbio, Transgene SA, Touchlight Genetics Ltd, Selecta Biosciences Inc, MedImmune LLC, Inovio Pharmaceuticals Inc, Immunovaccine Inc, iBio Inc and Hookipa Biotech AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Human Papillomavirus Protein E7 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Papillomavirus Protein E7 Market by Company

VLPbio

Transgene SA

Touchlight Genetics Ltd

Selecta Biosciences Inc

MedImmune LLC

Inovio Pharmaceuticals Inc

Immunovaccine Inc

iBio Inc

Hookipa Biotech AG

Genexine Inc

Formune SL

Etubics Corp

Cancer Research Technology Ltd

BioNTech AG

Bioleaders Corp

Advaxis Inc

Abion Inc

Human Papillomavirus Protein E7 Segment by Type

CUE-201

CerviVax

CUE-101

BLSILSB-710c

Others

Human Papillomavirus Protein E7 Segment by Application

Rectal Cancer

Penile Cancer

Anal Cancer

Lung Cancer

Others

Human Papillomavirus Protein E7 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Papillomavirus Protein E7 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Papillomavirus Protein E7 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Papillomavirus Protein E7.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human Papillomavirus Protein E7 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human Papillomavirus Protein E7 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human Papillomavirus Protein E7 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Papillomavirus Protein E7 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human Papillomavirus Protein E7 Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Human Papillomavirus Protein E7 Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human Papillomavirus Protein E7 Revenue of Manufacturers (2021-2026) Table 9. Global Human Papillomavirus Protein E7 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human Papillomavirus Protein E7 Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Human Papillomavirus Protein E7 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human Papillomavirus Protein E7, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human Papillomavirus Protein E7, Product Type & Application Table 14. Global Human Papillomavirus Protein E7 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human Papillomavirus Protein E7 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. VLPbio Company Information Table 19. VLPbio Business Overview Table 20. VLPbio Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. VLPbio Human Papillomavirus Protein E7 Product Portfolio Table 22. VLPbio Recent Developments Table 23. Transgene SA Company Information Table 24. Transgene SA Business Overview Table 25. Transgene SA Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Transgene SA Human Papillomavirus Protein E7 Product Portfolio Table 27. Transgene SA Recent Developments Table 28. Touchlight Genetics Ltd Company Information Table 29. Touchlight Genetics Ltd Business Overview Table 30. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Product Portfolio Table 32. Touchlight Genetics Ltd Recent Developments Table 33. Selecta Biosciences Inc Company Information Table 34. Selecta Biosciences Inc Business Overview Table 35. Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Selecta Biosciences Inc Human Papillomavirus Protein E7 Product Portfolio Table 37. Selecta Biosciences Inc Recent Developments Table 38. MedImmune LLC Company Information Table 39. MedImmune LLC Business Overview Table 40. MedImmune LLC Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. MedImmune LLC Human Papillomavirus Protein E7 Product Portfolio Table 42. MedImmune LLC Recent Developments Table 43. Inovio Pharmaceuticals Inc Company Information Table 44. Inovio Pharmaceuticals Inc Business Overview Table 45. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Product Portfolio Table 47. Inovio Pharmaceuticals Inc Recent Developments Table 48. Immunovaccine Inc Company Information Table 49. Immunovaccine Inc Business Overview Table 50. Immunovaccine Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Immunovaccine Inc Human Papillomavirus Protein E7 Product Portfolio Table 52. Immunovaccine Inc Recent Developments Table 53. iBio Inc Company Information Table 54. iBio Inc Business Overview Table 55. iBio Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. iBio Inc Human Papillomavirus Protein E7 Product Portfolio Table 57. iBio Inc Recent Developments Table 58. Hookipa Biotech AG Company Information Table 59. Hookipa Biotech AG Business Overview Table 60. Hookipa Biotech AG Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hookipa Biotech AG Human Papillomavirus Protein E7 Product Portfolio Table 62. Hookipa Biotech AG Recent Developments Table 63. Genexine Inc Company Information Table 64. Genexine Inc Business Overview Table 65. Genexine Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Genexine Inc Human Papillomavirus Protein E7 Product Portfolio Table 67. Genexine Inc Recent Developments Table 68. Formune SL Company Information Table 69. Formune SL Business Overview Table 70. Formune SL Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Formune SL Human Papillomavirus Protein E7 Product Portfolio Table 72. Formune SL Recent Developments Table 73. Etubics Corp Company Information Table 74. Etubics Corp Business Overview Table 75. Etubics Corp Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Etubics Corp Human Papillomavirus Protein E7 Product Portfolio Table 77. Etubics Corp Recent Developments Table 78. Cancer Research Technology Ltd Company Information Table 79. Cancer Research Technology Ltd Business Overview Table 80. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Product Portfolio Table 82. Cancer Research Technology Ltd Recent Developments Table 83. BioNTech AG Company Information Table 84. BioNTech AG Business Overview Table 85. BioNTech AG Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. BioNTech AG Human Papillomavirus Protein E7 Product Portfolio Table 87. BioNTech AG Recent Developments Table 88. Bioleaders Corp Company Information Table 89. Bioleaders Corp Business Overview Table 90. Bioleaders Corp Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bioleaders Corp Human Papillomavirus Protein E7 Product Portfolio Table 92. Bioleaders Corp Recent Developments Table 93. Advaxis Inc Company Information Table 94. Advaxis Inc Business Overview Table 95. Advaxis Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Advaxis Inc Human Papillomavirus Protein E7 Product Portfolio Table 97. Advaxis Inc Recent Developments Table 98. Abion Inc Company Information Table 99. Abion Inc Business Overview Table 100. Abion Inc Human Papillomavirus Protein E7 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Abion Inc Human Papillomavirus Protein E7 Product Portfolio Table 102. Abion Inc Recent Developments Table 103. Global Human Papillomavirus Protein E7 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Human Papillomavirus Protein E7 Sales by Region (2021-2026) & (K Units) Table 105. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2021-2026) Table 106. Global Human Papillomavirus Protein E7 Sales by Region (2027-2032) & (K Units) Table 107. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2027-2032) Table 108. Global Human Papillomavirus Protein E7 Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2021-2026) Table 110. Global Human Papillomavirus Protein E7 Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2027-2032) Table 112. North America Human Papillomavirus Protein E7 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 114. North America Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 115. North America Human Papillomavirus Protein E7 Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Human Papillomavirus Protein E7 Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Human Papillomavirus Protein E7 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 119. Europe Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 120. Europe Human Papillomavirus Protein E7 Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Human Papillomavirus Protein E7 Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Human Papillomavirus Protein E7 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Human Papillomavirus Protein E7 Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Human Papillomavirus Protein E7 Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Human Papillomavirus Protein E7 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 129. South America Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 130. South America Human Papillomavirus Protein E7 Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Human Papillomavirus Protein E7 Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Human Papillomavirus Protein E7 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Human Papillomavirus Protein E7 Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Human Papillomavirus Protein E7 Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Human Papillomavirus Protein E7 Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Human Papillomavirus Protein E7 Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Human Papillomavirus Protein E7 Sales by Type (2021-2026) & (K Units) Table 138. Global Human Papillomavirus Protein E7 Sales by Type (2027-2032) & (K Units) Table 139. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2026) Table 140. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2027-2032) Table 141. Global Human Papillomavirus Protein E7 Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Human Papillomavirus Protein E7 Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2026) Table 144. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2027-2032) Table 145. Global Human Papillomavirus Protein E7 Price by Type (2021-2026) & (US$/Unit) Table 146. Global Human Papillomavirus Protein E7 Price by Type (2027-2032) & (US$/Unit) Table 147. Global Human Papillomavirus Protein E7 Sales by Application (2021-2026) & (K Units) Table 148. Global Human Papillomavirus Protein E7 Sales by Application (2027-2032) & (K Units) Table 149. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2026) Table 150. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2027-2032) Table 151. Global Human Papillomavirus Protein E7 Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Human Papillomavirus Protein E7 Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2026) Table 154. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2027-2032) Table 155. Global Human Papillomavirus Protein E7 Price by Application (2021-2026) & (US$/Unit) Table 156. Global Human Papillomavirus Protein E7 Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Human Papillomavirus Protein E7 Distributors List Table 160. Human Papillomavirus Protein E7 Customers List Table 161. Human Papillomavirus Protein E7 Industry Trends Table 162. Human Papillomavirus Protein E7 Industry Drivers Table 163. Human Papillomavirus Protein E7 Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Papillomavirus Protein E7 Product Image Figure 5. Global Human Papillomavirus Protein E7 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human Papillomavirus Protein E7 Market Size (2021-2032) & (US$ Million) Figure 7. Global Human Papillomavirus Protein E7 Sales (2021-2032) & (K Units) Figure 8. Global Human Papillomavirus Protein E7 Average Price (US$/Unit) & (2021-2032) Figure 9. CUE-201 Product Image Figure 10. CerviVax Product Image Figure 11. CUE-101 Product Image Figure 12. BLSILSB-710c Product Image Figure 13. Others Product Image Figure 14. Rectal Cancer Product Image Figure 15. Penile Cancer Product Image Figure 16. Anal Cancer Product Image Figure 17. Lung Cancer Product Image Figure 18. Others Product Image Figure 19. Global Human Papillomavirus Protein E7 Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Human Papillomavirus Protein E7, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Human Papillomavirus Protein E7 Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Human Papillomavirus Protein E7 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Human Papillomavirus Protein E7 Sales by Region in 2025 Figure 25. Global Human Papillomavirus Protein E7 Revenue by Region in 2025 Figure 26. North America Human Papillomavirus Protein E7 Market Size by Country in 2025 Figure 27. North America Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 28. North America Human Papillomavirus Protein E7 Revenue Market Share by Country (2021-2032) Figure 29. United States Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Human Papillomavirus Protein E7 Market Size by Country in 2025 Figure 32. Europe Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 33. Europe Human Papillomavirus Protein E7 Revenue Market Share by Country (2021-2032) Figure 34. Germany Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Human Papillomavirus Protein E7 Market Size by Country in 2025 Figure 40. Asia Pacific Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Human Papillomavirus Protein E7 Revenue Market Share by Country (2021-2032) Figure 42. China Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Human Papillomavirus Protein E7 Market Size by Country in 2025 Figure 51. South America Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 52. South America Human Papillomavirus Protein E7 Revenue Market Share by Country (2021-2032) Figure 53. Mexico Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Human Papillomavirus Protein E7 Market Size by Country in 2025 Figure 57. Middle East and Africa Human Papillomavirus Protein E7 Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Human Papillomavirus Protein E7 Revenue Market Share by Country (2021-2032) Figure 59. Turkey Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Human Papillomavirus Protein E7 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2032) Figure 63. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2032) Figure 64. Global Human Papillomavirus Protein E7 Price (US$/Unit) by Type (2021-2032) Figure 65. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2032) Figure 66. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2032) Figure 67. Global Human Papillomavirus Protein E7 Price (US$/Unit) by Application (2021-2032) Figure 68. Human Papillomavirus Protein E7 Value Chain Figure 69. Human Papillomavirus Protein E7 Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Human Papillomavirus Protein E7 Industry Opportunities and Challenges

Scope & coverage.

Types
  • CUE-201
  • CerviVax
  • CUE-101
  • BLSILSB-710c
  • Others
Applications
  • Rectal Cancer
  • Penile Cancer
  • Anal Cancer
  • Lung Cancer
  • Others
Companies covered
  • VLPbio
  • Transgene SA
  • Touchlight Genetics Ltd
  • Selecta Biosciences Inc
  • MedImmune LLC
  • Inovio Pharmaceuticals Inc
  • Immunovaccine Inc
  • iBio Inc
  • Hookipa Biotech AG
  • Genexine Inc
  • Formune SL
  • Etubics Corp
  • Cancer Research Technology Ltd
  • BioNTech AG
  • Bioleaders Corp
  • Advaxis Inc
  • Abion Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human Papillomavirus Protein E7 Market Size (2021-2032)
  4. 2.2.2 Global Human Papillomavirus Protein E7 Sales (2021-2032)
  5. 2.2.3 Global Human Papillomavirus Protein E7 Market Average Price (2021-2032)
  6. 2.3 Human Papillomavirus Protein E7 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 CUE-201
  9. 2.3.3 CerviVax
  10. 2.3.4 CUE-101
  11. 2.3.5 BLSILSB-710c
  12. 2.3.6 Others
  13. 2.4 Human Papillomavirus Protein E7 by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Rectal Cancer
  16. 2.4.3 Penile Cancer
  17. 2.4.4 Anal Cancer
  18. 2.4.5 Lung Cancer
  19. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human Papillomavirus Protein E7 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human Papillomavirus Protein E7 Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Human Papillomavirus Protein E7 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human Papillomavirus Protein E7 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human Papillomavirus Protein E7 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human Papillomavirus Protein E7, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human Papillomavirus Protein E7, Product Type & Application
  8. 3.8 Global Manufacturers of Human Papillomavirus Protein E7, Established Date
  9. 3.9 Global Human Papillomavirus Protein E7 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 VLPbio
  2. 4.1.1 VLPbio Company Information
  3. 4.1.2 VLPbio Business Overview
  4. 4.1.3 VLPbio Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 VLPbio Human Papillomavirus Protein E7 Product Portfolio
  6. 4.1.5 VLPbio Recent Developments
  7. 4.2 Transgene SA
  8. 4.2.1 Transgene SA Company Information
  9. 4.2.2 Transgene SA Business Overview
  10. 4.2.3 Transgene SA Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Transgene SA Human Papillomavirus Protein E7 Product Portfolio
  12. 4.2.5 Transgene SA Recent Developments
  13. 4.3 Touchlight Genetics Ltd
  14. 4.3.1 Touchlight Genetics Ltd Company Information
  15. 4.3.2 Touchlight Genetics Ltd Business Overview
  16. 4.3.3 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Product Portfolio
  18. 4.3.5 Touchlight Genetics Ltd Recent Developments
  19. 4.4 Selecta Biosciences Inc
  20. 4.4.1 Selecta Biosciences Inc Company Information
  21. 4.4.2 Selecta Biosciences Inc Business Overview
  22. 4.4.3 Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Selecta Biosciences Inc Human Papillomavirus Protein E7 Product Portfolio
  24. 4.4.5 Selecta Biosciences Inc Recent Developments
  25. 4.5 MedImmune LLC
  26. 4.5.1 MedImmune LLC Company Information
  27. 4.5.2 MedImmune LLC Business Overview
  28. 4.5.3 MedImmune LLC Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 MedImmune LLC Human Papillomavirus Protein E7 Product Portfolio
  30. 4.5.5 MedImmune LLC Recent Developments
  31. 4.6 Inovio Pharmaceuticals Inc
  32. 4.6.1 Inovio Pharmaceuticals Inc Company Information
  33. 4.6.2 Inovio Pharmaceuticals Inc Business Overview
  34. 4.6.3 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Product Portfolio
  36. 4.6.5 Inovio Pharmaceuticals Inc Recent Developments
  37. 4.7 Immunovaccine Inc
  38. 4.7.1 Immunovaccine Inc Company Information
  39. 4.7.2 Immunovaccine Inc Business Overview
  40. 4.7.3 Immunovaccine Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Immunovaccine Inc Human Papillomavirus Protein E7 Product Portfolio
  42. 4.7.5 Immunovaccine Inc Recent Developments
  43. 4.8 iBio Inc
  44. 4.8.1 iBio Inc Company Information
  45. 4.8.2 iBio Inc Business Overview
  46. 4.8.3 iBio Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 iBio Inc Human Papillomavirus Protein E7 Product Portfolio
  48. 4.8.5 iBio Inc Recent Developments
  49. 4.9 Hookipa Biotech AG
  50. 4.9.1 Hookipa Biotech AG Company Information
  51. 4.9.2 Hookipa Biotech AG Business Overview
  52. 4.9.3 Hookipa Biotech AG Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hookipa Biotech AG Human Papillomavirus Protein E7 Product Portfolio
  54. 4.9.5 Hookipa Biotech AG Recent Developments
  55. 4.10 Genexine Inc
  56. 4.10.1 Genexine Inc Company Information
  57. 4.10.2 Genexine Inc Business Overview
  58. 4.10.3 Genexine Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Genexine Inc Human Papillomavirus Protein E7 Product Portfolio
  60. 4.10.5 Genexine Inc Recent Developments
  61. 4.11 Formune SL
  62. 4.11.1 Formune SL Company Information
  63. 4.11.2 Formune SL Business Overview
  64. 4.11.3 Formune SL Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Formune SL Human Papillomavirus Protein E7 Product Portfolio
  66. 4.11.5 Formune SL Recent Developments
  67. 4.12 Etubics Corp
  68. 4.12.1 Etubics Corp Company Information
  69. 4.12.2 Etubics Corp Business Overview
  70. 4.12.3 Etubics Corp Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Etubics Corp Human Papillomavirus Protein E7 Product Portfolio
  72. 4.12.5 Etubics Corp Recent Developments
  73. 4.13 Cancer Research Technology Ltd
  74. 4.13.1 Cancer Research Technology Ltd Company Information
  75. 4.13.2 Cancer Research Technology Ltd Business Overview
  76. 4.13.3 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Product Portfolio
  78. 4.13.5 Cancer Research Technology Ltd Recent Developments
  79. 4.14 BioNTech AG
  80. 4.14.1 BioNTech AG Company Information
  81. 4.14.2 BioNTech AG Business Overview
  82. 4.14.3 BioNTech AG Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 BioNTech AG Human Papillomavirus Protein E7 Product Portfolio
  84. 4.14.5 BioNTech AG Recent Developments
  85. 4.15 Bioleaders Corp
  86. 4.15.1 Bioleaders Corp Company Information
  87. 4.15.2 Bioleaders Corp Business Overview
  88. 4.15.3 Bioleaders Corp Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bioleaders Corp Human Papillomavirus Protein E7 Product Portfolio
  90. 4.15.5 Bioleaders Corp Recent Developments
  91. 4.16 Advaxis Inc
  92. 4.16.1 Advaxis Inc Company Information
  93. 4.16.2 Advaxis Inc Business Overview
  94. 4.16.3 Advaxis Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Advaxis Inc Human Papillomavirus Protein E7 Product Portfolio
  96. 4.16.5 Advaxis Inc Recent Developments
  97. 4.17 Abion Inc
  98. 4.17.1 Abion Inc Company Information
  99. 4.17.2 Abion Inc Business Overview
  100. 4.17.3 Abion Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Abion Inc Human Papillomavirus Protein E7 Product Portfolio
  102. 4.17.5 Abion Inc Recent Developments
5 Global Human Papillomavirus Protein E7 Market Scenario by Region
  1. 5.1 Global Human Papillomavirus Protein E7 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human Papillomavirus Protein E7 Sales by Region: 2021-2032
  3. 5.2.1 Global Human Papillomavirus Protein E7 Sales by Region: 2021-2026
  4. 5.2.2 Global Human Papillomavirus Protein E7 Sales by Region: 2027-2032
  5. 5.3 Global Human Papillomavirus Protein E7 Revenue by Region: 2021-2032
  6. 5.3.1 Global Human Papillomavirus Protein E7 Revenue by Region: 2021-2026
  7. 5.3.2 Global Human Papillomavirus Protein E7 Revenue by Region: 2027-2032
  8. 5.4 North America Human Papillomavirus Protein E7 Market Facts & Figures by Country
  9. 5.4.1 North America Human Papillomavirus Protein E7 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  11. 5.4.3 North America Human Papillomavirus Protein E7 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Human Papillomavirus Protein E7 Market Facts & Figures by Country
  15. 5.5.1 Europe Human Papillomavirus Protein E7 Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  17. 5.5.3 Europe Human Papillomavirus Protein E7 Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Human Papillomavirus Protein E7 Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Human Papillomavirus Protein E7 Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Human Papillomavirus Protein E7 Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Human Papillomavirus Protein E7 Market Facts & Figures by Country
  35. 5.7.1 South America Human Papillomavirus Protein E7 Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  37. 5.7.3 South America Human Papillomavirus Protein E7 Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Human Papillomavirus Protein E7 Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Human Papillomavirus Protein E7 Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Human Papillomavirus Protein E7 Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Human Papillomavirus Protein E7 Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Human Papillomavirus Protein E7 Sales by Type (2021-2032)
  2. 6.1.1 Global Human Papillomavirus Protein E7 Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Human Papillomavirus Protein E7 Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human Papillomavirus Protein E7 Revenue by Type (2021-2032)
  5. 6.2.1 Global Human Papillomavirus Protein E7 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human Papillomavirus Protein E7 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human Papillomavirus Protein E7 Sales by Application (2021-2032)
  2. 7.1.1 Global Human Papillomavirus Protein E7 Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Human Papillomavirus Protein E7 Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human Papillomavirus Protein E7 Revenue by Application (2021-2032)
  5. 7.2.1 Global Human Papillomavirus Protein E7 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human Papillomavirus Protein E7 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human Papillomavirus Protein E7 Value Chain Analysis
  2. 8.1.1 Human Papillomavirus Protein E7 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human Papillomavirus Protein E7 Production Mode & Process
  5. 8.2 Human Papillomavirus Protein E7 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human Papillomavirus Protein E7 Distributors
  8. 8.2.3 Human Papillomavirus Protein E7 Customers
9 Global Human Papillomavirus Protein E7 Analyzing Market Dynamics
  1. 9.1 Human Papillomavirus Protein E7 Industry Trends
  2. 9.2 Human Papillomavirus Protein E7 Industry Drivers
  3. 9.3 Human Papillomavirus Protein E7 Industry Opportunities and Challenges
  4. 9.4 Human Papillomavirus Protein E7 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst